课题基金 / 基金详情

Development of antisense-based small RNA agents targeting the GAG open reading frame of HIV-1 RNA for use in gene and drug therapy against HIV-1 infection.

Development of antisense-based small RNA agents targeting the GAG open reading frame of HIV-1 RNA for use in gene and drug therapy against HIV-1 infection.
开发针对 HIV-1 RNA 的 GAG 开放阅读框的基于反义的小 RNA 药物，用于针对 HIV-1 感染的基因和药物治疗。
批准号：
293899
负责人：
Gatignol Anne
金额：
$11.62万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-09-01 至 2014-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=293899&lang=en
关键词：
Antivirals Cell Culture Gene Therapy Hiv Lymphocytes Monocytes Ribozymes Rna Drugs Rna Interference Viral Growth

项目摘要

项目成果

Gatignol Anne的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Drug therapies for HIV infection are able to prevent the development of AIDS, however, they are unable to eliminate the HIV virus. As a result, intensive drug regimens must be maintained to delay disease progression, and are associated with a number of he
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of RNA therapies against SARS-CoV-2, other coronaviruses and influenza viruses for pandemic preparedness
COVID-19 Variant Supplement - Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Development of small RNAs for HIV-1 gene and drug therapy
海外基金